Head and neck cancers, Nasopharyngeal cancer, Pharyngeal cancer
Results
Phase 1
This trial looked at whether a vaccine containing the Epstein Barr virus (EBV) can boost immunity against EBV in people who have nasopharyngeal cancer.
This trial was supported by Cancer Research UK.
Recruitment start: 1 December 2005
Recruitment end: 21 April 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Neil Steven
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/05/034.
Last reviewed: 13 June 2012
CRUK internal database number: 499
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
